Advertisement

Topics

GLAUKOS CORPORATION Company Profile

09:47 EDT 20th June 2018 | BioPortfolio

Glaukos Corporation is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiologic outflow as a foundation of significant, steady and sustained glaucoma management.
Today, we are at the beginning with an innovative micro technology. In collaboration with our clinician partners, we are building technology towards a safer and more effective treatment for preserving vision in patients with primary open-angle glaucoma.

Location

26051 Merit Circle Suite 103
Laguna Hills
California
92653
United States of America

Contact

Phone: 949.367.9600
Fax: 949.367.9984
Email: contact@glaukos.com


News Articles [121 Associated News Articles listed on BioPortfolio]

Glaukos files patent lawsuit against Ivantis

Glaukos Corporation filed a patent infringement lawsuit against Ivantis Inc., according to a company press release.Filed in the U.S. District Court for the Central District of California, Southern Div...

Glaukos seeks to ‘transform glaucoma therapy’

Four new iStent devices are in the product pipeline, along with an intraocular drug delivery device, according to Thomas W. Burns, president and CEO of Glaukos, at the 36th Annual J.P. Morgan Healthca...

IDE application for three-stent system submitted by Glaukos to FDA

An application for investigational device exemption has been submitted by Glaukos to the FDA to conduct a prospective, multic -More- 

Premarket application for glaucoma treatment stent submitted by Glaukos

An application for premarket approval of the iStent Inject trabecular microbypass was submitted by Glaukos to the FDA.  -More- 

Glaukos Announces Participation in J.P. Morgan Healthcare Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to tra...

Glaukos Announces Participation in 30th Annual ROTH Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to tra...

Study shows positive results for Glaukos' trabecular microbypass stent

A study in the Journal of Glaucoma showed the use of Glaukos' iStent trabecular microbypass stent in cataract surgery demonst -More- 

Glaukos Announces Participation in Bank of America Merrill Lynch 2018 Health Care Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustai...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects

The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in refractory open-angle glaucoma subjec...

A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent

Glaucoma is the commonest cause of irreversible blindness in the world. Treatment centres around lowering intraocular pressure (IOP) and typically includes medication (least invasive), las...

Companies [174 Associated Companies listed on BioPortfolio]

GLAUKOS CORPORATION

Glaukos Corporation is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiol...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

Hot Spring Spas

Hot Spring Spas is the world’s leading brand of hot tubs and is sold through a network of more than 700 independent dealers throughout North America and 70 countries around t...

More Information about "GLAUKOS CORPORATION" on BioPortfolio

We have published hundreds of GLAUKOS CORPORATION news stories on BioPortfolio along with dozens of GLAUKOS CORPORATION Clinical Trials and PubMed Articles about GLAUKOS CORPORATION for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GLAUKOS CORPORATION Companies in our database. You can also find out about relevant GLAUKOS CORPORATION Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record